Hisun Pharmaceutical and Pfizer have signed JV framework contract with tentative name Hisun-Pfizer Pharmaceutical with registered capital of $250 million, but a total invested amount of $295 million. Hisun will hold 51% of the...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)